Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.
Saved in:
| Title: | Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors. |
|---|---|
| Authors: | Wang D; Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI, 48202, USA. dwang1@hfhs.org., Braiteh F; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA., Lee JJ; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Denlinger CS; Fox Chase Cancer Center, Philadelphia, PA, USA., Shepard DR; Cleveland Clinic, Cleveland, OH, USA., Chaudhary A; Eli Lilly and Company, Indianapolis, IN, USA., Lin Y; Eli Lilly and Company, Indianapolis, IN, USA., Gao L; Eli Lilly and Company, Bridgewater, NJ, USA., Asakiewicz C; Eli Lilly and Company, Bridgewater, NJ, USA., Nasroulah F; Eli Lilly and Company, Bridgewater, NJ, USA., LoRusso P; Yale Cancer Center, New Haven, CT, USA. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Oct; Vol. 78 (4), pp. 727-33. Date of Electronic Publication: 2016 Aug 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1432-0843 |
|---|---|
| DOI: | 10.1007/s00280-016-3125-4 |
